Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
Ultralow Dose PET Imaging for PSMA Expression
for
Healthy Volunteer, Prostate CA
Location: Englewood NJ
Sponsor: Akiva Mintz
Sex: All
Age: 18 - 70+
Code: NCT06904313
Phase 2, Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: New York NY, Hackensack NJ, Paterson NJ,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00358943
Recruiting
Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Brick NJ, Boston MA, Ford City PA, Kittanning PA,
Sponsor: SerenaGroup, Inc.
Sex: All
Age: 18+
Code: NCT02609594
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
for
Episodic Migraine
Location: Morristown NJ, Philadelphia PA, Amherst NY, Franklin VA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05711394
Phase 3, Recruiting
Ultralow Dose PET Imaging of 18F-FDG Uptake
for
Healthy Volunteer, Cancer
Location: Englewood NJ
Sponsor: Akiva Mintz
Sex: All
Age: 18 - 70+
Code: NCT06956391
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
for
Healthy (Controls), Healthy Volunteers,
Location: Englewood NJ
Sponsor: Akiva Mintz
Sex: All
Age: 18 - 70+
Code: NCT07284589
Phase 2, Recruiting
Ultralow Dose PET Imaging for 18F-NaF Uptake
for
Healthy Volunteer, Bone Alteration, Bone and Joint Cancer,
Location: Englewood NJ
Sponsor: Akiva Mintz
Sex: All
Age: 18 - 70+
Code: NCT07284563
Phase 2, Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Hackensack NJ, Morristown NJ, New Brunswick NJ,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT06423911
Phase 3, Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors